AI In Pharma Global Market Opportunities And Strategies To 2032

AI In Pharma Market 2023 – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research And Development, Epidemic Prediction), And By Region, Opportunities And Strategies – Global Forecast To 2032

Name: AI In Pharma Global Market Opportunities And Strategies To 2032
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

AI In Pharma Global Market Opportunities And Strategies To 2032

Starting Price : $4000.00 $2800.00 | Pages : 259 | Published : March 2024 | | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

AI In Pharma Market Definition

The artificial intelligence (AI) in pharma market consists of sales, by entities (organizations, sole proprietors and partnerships), of AI software products in pharma that use an automated algorithm to perform tasks that traditionally rely on human intelligence. It can be useful in handling data and presenting results that encourage better decision-making and save human efforts, cost and time.

AI is concerned with the simulation of human intelligence in machines that are programmed to think like humans and simulate their actions. AI in pharma refers to the system of interconnected and automated technologies in the pharmaceutical and biotechnology industries that can function autonomously with little or no human intervention. It can help pharmaceutical companies improve clinical trials, enable predictive power in the R&D (research and development) process and elevate pharma manufacturing.

Book your 30 minutes free consultation with our research experts

AI In Pharma Market Size

The global AI in pharma market reached a value of nearly $1,477.78 million in 2022, having grown at a compound annual growth rate (CAGR) of 35.8% since 2017. The market is expected to grow from $1,477.78 million in 2022 to $6,291.91 million in 2027 at a rate of 33.6%. The market is then expected to grow at a CAGR of 18.9% from 2027 and reach $14,958.94 million in 2032.

Growth in the historic period resulted from strong economic growth in emerging markets, increased adoption of artificial intelligence (AI) for cost efficient drug discovery and rising implementation of AI in radiology. Factors that negatively affected growth in the historic period was high rate of AI project failures and low healthcare access.

Going forward, adoption of cloud-based applications and services by pharma companies, increasing healthcare expenditure and growing government support rising to AI development will drive the growth. Factor that could hinder the growth of the AI in pharma market in the future include lack of skilled professionals.

AI In Pharma Market Drivers

The key drivers of the AI in pharma market include:

Rising Adoption Of Cloud-Based Applications And Services By Pharma Companies

The rising adoption of cloud-based applications and services by pharmaceutical companies is expected to propel the growth of the AI in pharma market going forward. Cloud-based drug discovery platforms are a cutting-edge method of conducting research and development in the pharmaceutical industry. They leverage data analytics and cloud computing technologies to enhance drug discovery procedures, offering a wide range of tools and functionalities necessary for different facets of drug research and discovery. These platforms improve the efficiency, economy and collaboration of the processes. Pharmaceutical companies are significant market participants and end-users of these platforms, which help these companies handle large amounts of clinical, chemical and biological data by providing secure data storage options. In March 2023, Nvidia Corporation, a US-based technology company, launched BioNeMo Cloud, to streamline life sciences research, drug discovery and protein engineering. The software provides researchers with access to pre-trained AI models, allowing for customization with proprietary data. Offered as a cloud service, BioNeMo Cloud enables accelerated drug discovery workflows, with US-based biotech company Amgen and several startups already utilizing the platform. Therefore, the increasing adoption of cloud-based applications and services by pharmaceutical companies will drive the AI in pharma market growth during the forecast period.

AI In Pharma Market Restraints

The key restraints on the AI in pharma market include:

Lack Of Skilled Professionals

The lack of skilled professionals is expected to restrain the growth of the AI in pharma market during the forecast period. The implementation of AI technologies requires specialized skills in data science, machine learning and AI algorithms. The lack of AI professionals could result in longer delays in getting new drugs to market and higher costs for pharma companies developing them. According to the Global AI Adoption Index 2022 by IBM, a US-based technology company, the barrier to AI adoption for businesses is limited AI skills, expertise or knowledge, with 34% of companies reporting this as a hindrance. Therefore, the lack of skilled professionals may hamper the growth of the AI in pharma market.

AI In Pharma Market Trends

Major trends shaping the AI in pharma market include:

Introduction Of Generative AI In Pharma To Improve Medical Consultations

Companies in the market are increasingly focusing on using generative AI in pharma to improve medical consultations. Generative AI, a subfield of artificial intelligence that focuses on creating new data instances that resemble existing data, has been introduced into the pharmaceutical industry with the potential to revolutionize drug discovery and development and medical records management. For example, in October 2023, Ubie, a Japan-based medical AI startup, introduced a new Generative AI feature for doctors that streamlines medical record documentation and summarizes patient findings. This feature, known as the 'Medical Interview Summary Function,' uses a Large Language Model (LLM) to generate AI-based summaries from patient visits, specifically summarizing the 20-30 questions related to symptoms and lifestyle habits that patients answer on the 'Ubie Medical Navi' product. The LLM presents this summary on the doctor's PC screen, allowing doctors to quickly understand the patient's symptoms and concerns, thereby improving the quality of medical consultations

Use Of AI In Molecular Target Identification

Major companies operating in the AI in pharma market are increasing their focus on introducing AI in molecular target identification to gain a competitive edge in the market. AI tools are being widely used for molecular target identification and selection in the pharmaceutical industry. Target identification and selection involve discovering a possible molecular target with a specific biological action that is anticipated to have a defined therapeutic activity. In March 2023, Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-powered pharmaceutical company, integrated an advanced AI chat functionality called 'ChatPandaGPT' into its PandaOmics platform. PandaOmics is an AI-driven target discovery platform that applies deep learning models to identify therapeutic targets associated with a given disease through a combination of omics data analysis and contextual information from publications, clinical trials and grant applications.

Opportunities And Recommendations In The AI In Pharma Market

Opportunities – The top opportunities in the AI in pharma market segmented by technology will arise in the deep learning segment, which will gain $1,646.13 million of global annual sales by 2027. The top opportunities in the AI in pharma market segmented by drug type will arise in the small molecules segment, which will gain $2,806.31 million of global annual sales by 2027. The top opportunities in the AI in pharma market segmented by application will arise in the drug discovery segment, which will gain $3,708.16 million of global annual sales by 2027. The AI in pharma market size will gain the most in the USA at $1,230.85 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the AI in pharma companies to focus on introduction of generative AI in pharma, focus on use of AI in molecular target identification, focus on integration of AI in drug screening process, focus on growing investments to develop new product solutions, focus on fast-growing technologies, expand in emerging markets, continue to focus on developed markets, focus on strategic partnerships and collaborations, focus on competitive pricing, participate in trade shows and events, continue to focus on B2B promotions and continue to target fast-growing applications.

AI in pharma Market Segmentation

The AI In Pharma market is segmented by technology, by drug type and by application.

By Type –
The AI in pharma market is segmented by technology into:

a) Context-Aware Processing
b) Natural Language Processing
c) Querying Method
d) Deep Learning

The deep learning market was the largest segment of the AI in pharma market segmented by technology, accounting for 34.3% or $507.30 million of the total in 2022. Going forward, the context-aware processing segment is expected to be the fastest growing segment in the AI in pharma market segmented by technology, at a CAGR of 33.72% during 2022-2027.

By Drug Type –
The AI in pharma market is segmented by drug type into:

a) Small Molecule
b) Large Molecules

The small molecules market was the largest segment of the AI in pharma market segmented by drug type, accounting for 63.2% or $934.38 million of the total in 2022. Going forward, the large molecules segment is expected to be the fastest growing segment in the AI in pharma market segmented by drug type, at a CAGR of 36.2% during 2022-2027.

By Application Type –
The AI in pharma market is segmented by application type into:

a) Diagnosis
b) Clinical Trial Research
c) Drug Discovery
d) Research And Development
e) Epidemic Prediction

The drug discovery market was the largest segment of the financial advisory market segmented by application, accounting for 79.7% or $1,177.50 million of the total in 2022. Going forward, the clinical trial research segment is expected to be the fastest growing segment in the financial advisory market segmented by application, at a CAGR of 38.1% during 2022-2027.

By Geography - The AI in pharma market is segmented by geography into:

• China
• India
• Japan
• Australia
• Indonesia
• South Korea

• USA

• Brazil

• France
• Germany
• UK

• Russia

North America was the largest region in the AI in pharma market, accounting for 41.7% or $615.92 million of the total in 2022. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the AI in pharma market will be South America and Asia Pacific where growth will be at CAGRs of 42.3% and 40.4% respectively. These will be followed by Eastern Europe and Africa where the markets are expected to grow at CAGRs of 37.7% and 37.3% respectively.

AI In Pharma Market Competitive Landscape

Major Competitors are:

Concerto HealthAI

Alphabet Inc.

OWKIN

Nvidia Corporation

PathAI

Other Competitors Include:

Insilico Medicine

Exscientia

Microsoft Corporation

XtalPi

Intel

Shanghai Pharmaceuticals

Standigm

Takeda Pharmaceutical Company Ltd

Otsuka Pharmaceutical Co. Ltd

China National Pharmaceutical Group Co., Ltd. (Sinopharm)

Jiangsu Hengrui Medicine Co., Ltd

Cipla Limited

Aurobindo Pharma Limited

Dr. Reddy’s Laboratories Ltd

Sun Pharma

Roche India

Alliance Pharm Pte Ltd

GSK Australia

DeepMind

GlaxoSmithKline

Sanofi

Bayer

Renalytix AI

Merck

AstraZeneca

Exscientia

Iktos

BenevolentAI

Novartis

Gero

Ardigen

Insilico Medicine

Botkin

Webiomed

Care Mentor AI

Diagnocat

IBM Corporation

Atomwise, Inc

Cloud Pharmaceutical

Bioage

NuMedii

Envisagenics

Aria Pharmaceuticals

XtalPi

Verge Genomics

Berg LLC

Deep Genomics

Cyclica

IQVIA

Roche

Novartis

Pfizer

PRA Healthscience

Gesto

Intensicare

Epitrack

GE Healthcare

Welltok Inc

Oncora Medical

Recursion Pharmaceuticals Inc

Nucleai

Pepticom

IBM Watson

AstraZeneca

Rology

hearX Group

DilenyTech

iNNOHEALTH Technology Solutions

1Executive Summary

1.1AI In Pharma – Market Attractiveness And Macro economic Landscape

2Table Of Contents

3List Of Tables

4List Of Figures

5Report Structure

6Market Characteristics

6.1General Market Definition

6.2Summary

6.3AI In Pharma Market Definition And Segmentations

6.4Market Segmentation By Technology

6.4.1Context-Aware Processing

6.4.2Natural Language Processing

6.4.3Querying Method

6.4.4Deep Learning

6.5Market Segmentation By Drug Type

6.5.1Small Molecule

6.5.2Large Molecules

6.6Market Segmentation By Application

6.6.1Diagnosis

6.6.2Clinical Trial Research

6.6.3Drug Discovery

6.6.4Research And Development

6.6.5Epidemic Prediction

7Major Market Trends

7.1Introduction Of Generative AI In Pharma To Improve Medical Consultations

7.2Use Of AI In Molecular Target Identification

7.3Integration Of AI In Drug Screening Process To Accelerate Drug Development

7.4Growing Investments To Develop New Product Solutions

7.5Strategic Partnerships And Collaborations Among Market Players

8AI In Pharma Market - Macro Economic Scenario

8.1COVID-19 Impact On The AI In Pharma Market

8.2Impact Of The War In Ukraine On The AI In Pharma Market

8.3Impact Of High Inflation On The AI In Pharma Market

9Global Market Size and Growth

9.1Market Size

9.2Historic Market Growth, 2017 – 2022, Value ($ Million)

9.2.1Market Drivers 2017 – 2022

9.2.2Market Restraints 2017 – 2022

9.3Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

9.3.1Market Drivers 2022 – 2027

9.3.2Market Restraints 2022 – 2027

10Global AI In Pharma Market Segmentation

10.1Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

10.2Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

10.3Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

11AI In Pharma Market, Regional and Country Analysis

11.1Global AI In Pharma Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

11.2Global AI In Pharma Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12Asia-Pacific Market

12.1Summary

12.1.1Market Overview

12.1.2Region Information

12.1.3Market Information

12.1.4Background Information

12.1.5Government Initiatives

12.1.6Regulations

12.1.7Regulatory Bodies

12.1.8Major Associations

12.1.9Taxes Levied

12.1.10Corporate Tax Structure

12.1.11Investments

12.1.12Major Companies

12.2Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.3Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.4Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.5Asia-Pacific AI In Pharma Market: Country Analysis

12.6China Market

12.7Summary

12.7.1Market Overview

12.7.2Country Information

12.7.3Market Information

12.7.4Background Information

12.7.5Government Initiatives

12.7.6Regulations

12.7.7Regulatory Bodies

12.7.8Major Associations

12.7.9Taxes Levied

12.7.10Corporate Tax Structure

12.7.11Investments

12.7.12Major Companies

12.8China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.9China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.1China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.11India Market

12.12India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.13India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.14India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.15Japan Market

12.16Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.17Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.18Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.19Australia Market

12.2Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.21Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.22Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.23Indonesia Market

12.24Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.25Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.26Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.27South Korea Market

12.28South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.29South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.3South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13Western Europe Market

13.1Summary

13.1.1Market Overview

13.1.2Region Information

13.1.3Market Information

13.1.4Background Information

13.1.5Government Initiatives

13.1.6Regulations

13.1.7Regulatory Bodies

13.1.8Major Associations

13.1.9Taxes Levied

13.1.10Corporate Tax Structure

13.1.11Investments

13.1.12Major Companies

13.2Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.3Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.4Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.5Western Europe AI In Pharma Market: Country Analysis

13.6UK Market

13.7UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.8UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.9UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.1Germany Market

13.11Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.12Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.13Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.14France Market

13.15France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.16France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.17France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14Eastern Europe Market

14.1Summary

14.1.1Market Overview

14.1.2Region Information

14.1.3Market Information

14.1.4Background Information

14.1.5Government Initiatives

14.1.6Regulations

14.1.7Regulatory Bodies

14.1.8Major Associations

14.1.9Taxes Levied

14.1.10Corporate Tax Structure

14.1.11Investments

14.1.12Major Companies

14.2Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14.3Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14.4Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14.5Eastern Europe AI In Pharma Market: Country Analysis

14.6Russia Market

14.7Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14.8Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14.9Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15North America Market

15.1Summary

15.1.1Market Overview

15.1.2Region Information

15.1.3Market Information

15.1.4Background Information

15.1.5Government Initiatives

15.1.6Regulations

15.1.7Regulatory Bodies

15.1.8Major Associations

15.1.9Taxes Levied

15.1.10Corporate Tax Structure

15.1.11Investments

15.1.12Major Companies

15.2North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.3North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.4North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.5North America AI In Pharma Market: Country Analysis

15.6USA Market

15.7Summary

15.7.1Country Information

15.7.2Market Information

15.7.3Background Information

15.7.4Government Initiatives

15.7.5Regulations

15.7.6Regulatory Bodies

15.7.7Major Associations

15.7.8Taxes Levied

15.7.9Corporate Tax Structure

15.7.10Investments

15.7.11Major Companies

15.8USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.9USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.1USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16South America Market

16.1Summary

16.1.1Market Overview

16.1.2Region Information

16.1.3Market Information

16.1.4Background Information

16.1.5Government Initiatives

16.1.6Regulations

16.1.7Regulatory Bodies

16.1.8Major Associations

16.1.9Taxes Levied

16.1.10Corporate Tax Structure

16.1.11Investments

16.1.12Major Companies

16.2South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16.3South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16.4South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16.5South America AI In Pharma Market: Country Analysis

16.6Brazil Market

16.7Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16.8Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16.9Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

17Middle East Market

17.1Summary

17.1.1Market Overview

17.1.2Region Information

17.1.3Market Information

17.1.4Background Information

17.1.5Government Initiatives

17.1.6Regulations

17.1.7Regulatory Bodies

17.1.8Major Associations

17.1.9Taxes Levied

17.1.10Corporate Tax Structure

17.1.11Investments

17.1.12Major Companies

17.2Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

17.3Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

17.4Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

18Africa Market

18.1Summary

18.1.1Market Overview

18.1.2Region Information

18.1.3Market Information

18.1.4Background Information

18.1.5Government Initiatives

18.1.6Regulations

18.1.7Regulatory Bodies

18.1.8Major Associations

18.1.9Taxes Levied

18.1.10Corporate Tax Structure

18.1.11Investments

18.1.12Major Companies

18.2Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

18.3Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

18.4Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

19Competitive Landscape And Company Profiles

19.1Company Profiles

19.2Concerto HealthAI

19.2.1Company Overview

19.2.2Products And Services

19.2.3Business Strategy

19.2.4Financial Overview

19.3Alphabet Inc.

19.3.1Company Overview

19.3.2Products And Services

19.3.3Business Strategy

19.3.4Financial Overview

19.4OWKIN

19.4.1Company Overview

19.4.2Products And Services

19.4.3Business Strategy

19.4.4Financial Overview

19.5Nvidia Corporation

19.5.1Company Overview

19.5.2Products And Services

19.5.3Business Strategy

19.5.4Financial Overview

19.6PathAI

19.6.1Company Overview

19.6.2Products And Services

19.6.3Business Strategy

19.6.4Financial Overview

20Key Mergers And Acquisitions

20.1BioNTech Acquired InstaDeep

20.2Recursion Pharmaceuticals Acquired Cyclica And Valence

20.3Telix Pharmaceuticals Acquired Dedicaid GmbH

20.4Envision Pharma Group Acquired OKRA.ai

20.5Bayer AG Acquired Blackford Analysis Ltd

20.6iBio Acquired Rubryc Therapeutics

20.7Genentech Acquired Prescient Design

20.8Nurosene Health Inc Acquired Netramark Incorporated

20.9X-Chem Acquired Glamorous AI

21Opportunities And Strategies

21.1Global AI In Pharma Market In 2027 – Countries Offering Most New Opportunities

21.2Global AI In Pharma Market In 2027 – Segments Offering Most New Opportunities

21.3Global AI In Pharma Market In 2027 – Growth Strategies

21.3.1Market Trend Based Strategies

21.3.2Competitor Strategies

22AI In Pharma Market, Conclusions And Recommendations

22.1Conclusions

22.2Recommendations

22.2.1Product

22.2.2Place

22.2.3Price

22.2.4Promotion

22.2.5People

23Appendix

23.1Geographies Covered

23.2Market Data Sources

23.3Research Methodology

23.4Currencies

23.5The Business Research Company

23.6Copyright and Disclaimer

List Of Tables

Table 1: Global AI In Pharma Market, Historic, 2017 – 2022, $ Million

Table 2: Global AI In Pharma Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 3: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 4: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 5: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 6: Global AI In Pharma Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 7: Global AI In Pharma Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 8: Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 9: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 10: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 11: China GDP Per Capita, By Country, 2017-2022, $

Table 12: China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 13: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 14: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 15: India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 16: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 17: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 18: Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 19: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 20: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 21: Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 22: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 23: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 24: Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 25: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 26: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 27: South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 28: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 29: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 30: Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 31: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 32: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 33: UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 34: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 35: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 36: Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 37: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 38: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 39: France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 40: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 41: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 42: Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 43: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 44: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 45: Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 46: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 47: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 48: North America GDP Per Capita, By Country, 2017-2022, $

Table 49: North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 50: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 51: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 52: USA GDP Per Capita, By Country, 2017-2022, $

Table 53: USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 54: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 55: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 56: South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 57: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 58: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 59: Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 60: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 61: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 62: Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 63: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 64: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 65: Africa GDP Per Capita, By Country, 2017-2022, $

Table 66: Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 67: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 68: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 69: Global AI In Pharma Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)

Table 70: Concerto HealthAI – Financial Overview, 2018 – 2022, $ Billion

Table 71: Alphabet Inc – Financial Overview, 2018 – 2022, $ Billion

Table 72: OWKIN – Financial Overview, 2018 – 2022, $ Billion

Table 73: NVIDIA Corporation – Financial Overview, 2018 – 2022, $ Billion

Table 74: PathAI – Financial Overview, 2018 – 2022, $ Billion

Table 75: Global AI In Pharma Market Size Gain ($ Million), 2022 – 2027, By Country

Table 76: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Technology, 2022 – 2027

Table 77: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Drug Type, 2022 – 2027

Table 78: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Application, 2022 – 2027

Table 79: AI In Pharma Market Data Sources

List Of Figures

Figure 1: Global AI In Pharma Market Segmentation By Technology

Figure 2: Global AI In Pharma Market Segmentation By Drug Type

Figure 3: Global AI In Pharma Market Segmentation By Application

Figure 4: Global AI In Pharma Market, Historic, 2017 – 2022, $ Million

Figure 5: Global AI In Pharma Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 6: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 7: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 8: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 9: Global AI In Pharma Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 10: Global AI In Pharma Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 11: Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 12: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 13: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 14: China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 15: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 16: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 17: India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 18: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 19: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 20: Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 21: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 22: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 23: Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 24: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 25: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 26: Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 27: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 28: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 29: South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 30: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 31: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 32: Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 33: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 34: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 35: UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 36: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 37: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 38: Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 39: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 40: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 41: France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 42: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 43: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 44: Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 45: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 46: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 47: Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 48: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 49: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 50: North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 51: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 52: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 53: USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 54: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 55: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 56: South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 57: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 58: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 59: Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 60: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 61: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 62: Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 63: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 64: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 65: Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 66: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 67: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 68: Global AI In Pharma, Key Competitor Estimated Market Shares, 2022, Percentage (%)

Figure 69: Alphabet Inc – Financial Overview, 2018 – 2022, $ Billion

Figure 70: NVIDIA Corporation – Financial Overview, 2018 – 2022, $ Billion

Figure 71: Geographic Regions Covered

Opportunities And Strategies Analysis For The Automotive V2X Market – Includes Automotive V2X Market Share

Global Product Lifecycle Management Market Opportunities And Strategies – Forecast To 2030 – Includes Product Lifecycle Management Market Size

Global Session Initiation Protocol SIP Trunking Services Market Opportunities And Strategies – Forecast To 2030 – Includes Session Initiation Protocol (SIP) Trunking Services Market Overview

Insights On The Artificial Intelligence In Healthcare Market Size And Growth Rate – Includes Artificial Intelligence In Healthcare Market Size

The Business Research Company offers the blockchain distributed ledger market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the citizen services ai market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the p2p payment market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the scara robot market research report 2022 with industry size, share, segments and market growth

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024 – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecules, Large Molecules), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics), By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Biophotonics Global Market Report 2024 – By Product Technology (In-Vitro, In-Vivo), By Application (See-Through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors, Other Applications), By End Use (Diagnostics, Therapeutic, Tests, Other End Uses) – Market Size, Trends, And Global Forecast 2024-2033

View Report

3D Cell Culture Technologies Global Market Report 2024 – By Type (Scaffold-based, Scaffold-free, 3D Bioreactors), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine), By End Users (Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

3D Printed Implants Global Market Report 2024 – By Implantation Technology (Laser Beam Melting, Electronic Beam Melting, Droplet Deposition, Laminated Deposition, Two-photon Polymerization), By Application (Dental, Orthopedic, Cranio-maxillofacial), By End Users (Medical And Surgical Centers, Pharmaceutical Companies, Biotechnology Industry, Medical Institution) – Market Size, Trends, And Global Forecast 2024-2033

View Report

3D Printed Prosthetics Global Market Report 2024 – By Type (Sockets, Limbs, Joints, Covers, Other Types), By Material (Polypropylene, Polyethylene, Acrylics, Polyurethane), By End-User (Hospitals, Rehabilitation Centers, Prosthetic Clinics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Biosimilars Global Market Report 2024 – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones, Others), By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Synthetic Biology Global Market Report 2024 – By Technology (Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering), By Product Type (Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism), By Application (Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics, Other Application) – Market Size, Trends, And Global Forecast 2024-2033

View Report

CRISPR Technology Global Market Report 2024 – By Product Type (Design Tools, Plasmid And Vector, Cas9 And G-RNA, Delivery System Products), By Application (Biomedical, Agriculture, Diagnostics, Other Applications), By End-User (Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Research Organizations (CROs)) – Market Size, Trends, And Global Forecast 2024-2033

View Report

AI In Pharma Global Market Opportunities And Strategies To 2032

AI In Pharma Global Market Opportunities And Strategies To 2032

AI In Pharma Market Definition

AI In Pharma Market Size

AI In Pharma Market Drivers

AI In Pharma Market Restraints

AI In Pharma Market Trends

Opportunities And Recommendations In The AI In Pharma Market

AI in pharma Market Segmentation

AI In Pharma Market Competitive Landscape

Major Competitors are:

Other Competitors Include:

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions